申请人:Genzyme Corporation
公开号:US20140249165A1
公开(公告)日:2014-09-04
Provided herein are methods of treatment of a cystic disease by administering a compound of Formula I. In certain embodiments, the compound for use in the methods provided herein is roscovitine or an analog thereof.